type 2 diabetes

Oramed spearheading human oral insulin trials in 37 US centers
Fri, 05/10/19 - 10:40 am
Oramed
insulin
type 2 diabetes
diabetes
clinical trials
oral insulin
FDA approves AstraZeneca's triple combination therapy for type 2 diabetes
Healio
Fri, 05/3/19 - 11:19 am
AstraZeneca
type 2 diabetes
FDA
Qternmet XR
Novo seeks Victoza label expansion with fresh pediatric trial results
Biopharma Dive
Mon, 04/29/19 - 09:33 pm
Novo Nordisk
type 2 diabetes
pediatrics
Victoza
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Wed, 04/10/19 - 11:40 pm
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Intarcia licenses Numab's autoimmune therapy
BioCentury
Wed, 03/6/19 - 10:04 am
Intarcia
Numab
BD016
type 2 diabetes
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
Pharmaceutical Business Review
Thu, 02/28/19 - 11:45 pm
AstraZeneca
type 2 diabetes
Farxiga
Xigduo XR
FDA
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Thu, 01/3/19 - 09:45 am
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Mon, 11/26/18 - 12:30 pm
Zafgen
clinical trials
FDA
diabetes
ZGN-1061
type 2 diabetes
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Mon, 11/26/18 - 09:56 am
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes
Millions left behind as diabetes drives surge in insulin demand
Reuters
Wed, 11/21/18 - 09:52 am
diabetes
type 2 diabetes
insulin
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
Stat
Wed, 11/14/18 - 10:32 am
devices
digital coaching
type 2 diabetes
Virta Health
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Thu, 11/1/18 - 11:31 am
Janssen
JNJ
Invokana
type 2 diabetes
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Fierce Pharma
Wed, 10/31/18 - 11:52 am
JNJ
Invokana
type 2 diabetes
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Fierce Pharma
Mon, 10/29/18 - 11:45 am
patients
patient experience data
Sanofi
Novo Nordisk
type 2 diabetes
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells
Fierce Biotech
Mon, 10/22/18 - 12:17 pm
AstraZeneca
Ionis Pharmaceuticals
type 2 diabetes
antisense
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
CP Wire
Wed, 10/17/18 - 10:26 am
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Wed, 10/17/18 - 10:23 am
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
CP Wire
Wed, 10/10/18 - 10:13 am
Jardiance
Boehringer Ingelheim
Eli Lilly
diabetes
type 2 diabetes

Pages